Ken Fisher Fisher Asset Management
Ken Fisher is the founder and executive chairman of Fisher Investments, a global money management firm overseeing billions of dollars in assets. He gained early recognition for pioneering the use of the price-to-sales ratio in stock analysis and wrote the long-running “Portfolio Strategy” column in Forbes. Over the years, Fisher has authored numerous books on investing and wealth management, many of which have become bestsellers.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
|
+$558M |
| 2 |
Apple
AAPL
|
+$265M |
| 3 |
Microsoft
MSFT
|
+$209M |
| 4 |
Amazon
AMZN
|
+$197M |
| 5 |
Visa
V
|
+$180M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
COHR
Coherent Inc
COHR
|
+$86.3M |
| 2 |
TSMC
TSM
|
+$77.2M |
| 3 |
iShares MBS ETF
MBB
|
+$44.5M |
| 4 |
KSU
Kansas City Southern
KSU
|
+$43.8M |
| 5 |
Vale
VALE
|
+$28.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.97% |
| 2 | Financials | 12.67% |
| 3 | Consumer Discretionary | 11.32% |
| 4 | Healthcare | 10.27% |
| 5 | Communication Services | 7.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
326
Bristol-Myers Squibb
BMY
$135B
| $11.6M | 0.01% |
173,693
-1,665
| -0.9% | -$109K |
|
327
ACI Worldwide
ACIW
$5.82B
| $11.5M | 0.01% |
309,714
+32,669
| +12% | +$1.28M |
|
328
iShares MSCI France ETF
EWQ
$342M
| $11.4M | 0.01% |
302,488
-5,866
| -2% | -$222K |
|
|
NTUS
329
DELISTED
Natus Medical Inc
NTUS
| $11.4M | 0.01% |
439,338
+1,497
| +0.3% | +$40.7K |
|
330
Cavco Industries
CVCO
$4.36B
| $11.2M | 0.01% |
50,269
+451
| +0.9% | +$98.3K |
|
331
Curtiss-Wright
CW
$28B
| $11.1M | 0.01% |
93,653
-3,186
| -3% | -$398K |
|
|
AYX
332
DELISTED
Alteryx Inc
AYX
| $11M | 0.01% |
128,433
+1,042
| +0.8% | +$85.2K |
|
333
Materion
MTRN
$4.72B
| $11M | 0.01% |
145,906
+8,640
| +6% | +$640K |
|
334
ResMed
RMD
$32.4B
| $11M | 0.01% |
44,529
+8,224
| +23% | +$1.73M |
|
335
TechnipFMC
FTI
$27.5B
| $11M | 0.01% |
1,211,692
+164,480
| +16% | +$1.39M |
|
336
Global X Robotics & Artificial Intelligence ETF
BOTZ
$3.46B
| $10.9M | 0.01% |
312,793
-12,782
| -4% | -$438K |
|
337
UFP Industries
UFPI
$5.24B
| $10.1M | 0.01% |
135,959
-4,664
| -3% | -$368K |
|
338
Revvity
RVTY
$12.4B
| $10.1M | 0.01% |
65,409
+1,302
| +2% | +$183K |
|
339
iShares 1-3 Year Treasury Bond ETF
SHY
$25.1B
| $9.98M | 0.01% |
115,891
-16,004
| -12% | -$1.38M |
|
340
United Rentals
URI
$71.6B
| $9.91M | 0.01% |
31,072
-1,318
| -4% | -$426K |
|
341
Veracyte
VCYT
$3.73B
| $9.75M | 0.01% |
243,775
+132,571
| +119% | +$5.67M |
|
342
Equinor
EQNR
$93.1B
| $9.73M | 0.01% |
459,081
+4,771
| +1% | +$101K |
|
343
LivaNova
LIVN
$4.69B
| $9.52M | 0.01% |
113,192
| – | – |
|
|
FBGX
344
DELISTED
UBS AG FI Enhanced Large Cap Growth ETN
FBGX
| $9.01M | 0.01% |
13,003
-1,581
| -11% | -$993K |
|
345
Comcast
CMCSA
$88.5B
| $8.69M | 0.01% |
152,480
-10,314
| -6% | -$577K |
|
|
MDC
346
DELISTED
M.D.C. Holdings, Inc.
MDC
| $8.69M | 0.01% |
171,679
+4,002
| +2% | +$229K |
|
347
Huazhu Hotels Group
HTHT
$13B
| $8.67M | 0.01% |
164,152
| – | – |
|
348
PepsiCo
PEP
$190B
| $8.53M | 0.01% |
57,582
-1,216
| -2% | -$177K |
|
|
PCH
349
DELISTED
PotlatchDeltic
PCH
| $8.2M | 0.01% |
154,225
+2,219
| +1% | +$128K |
|
350
ICU Medical
ICUI
$4.3B
| $7.82M | ﹤0.01% |
38,000
-8
| -0% | -$1.65K |
|
Similar funds
Ken Fisher's Q2 2021 Portfolio in Review
As of Q2 2021, Ken Fisher held 1,100 positions worth $159B, up 12% from $142B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Ken Fisher deployed $4.92B of net new capital in Q2 2021, opening 101 new positions and adding to 388 existing holdings. Its largest new stake was Organon & Co: 967,460 shares worth $29.3M.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 26% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was TSMC, an estimated $77.2M trimmed.
- Ken Fisher's largest Q2 2021 buy was Organon & Co: 967,460 shares worth $29.3M.
- Ken Fisher added most to Vanguard Intermediate-Term Corporate Bond ETF in Q2 2021, an estimated $558M increase.
- Ken Fisher's biggest Q2 2021 reduction was TSMC, cutting an estimated $77.2M.
- Ken Fisher fully exited Coherent Inc in Q2 2021, selling an estimated $86.3M.
- Ken Fisher's ten largest holdings make up 32% of its $159B portfolio in Q2 2021.
- Ken Fisher opened 101 new positions and closed 90 in Q2 2021.
- Ken Fisher's portfolio value rose 12% quarter-over-quarter to $159B.
Based on Fisher Asset Management's 13F filing for Q2 2021, filed 27 Jul 2021.